Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Demographics and Length of stay in Hospitalized COVID 19 patients with Encephalopathy.
Infectious Disease
Infectious Disease Posters (7:00 AM-5:00 PM)
076
Our study is aimed at defining the epidemiological characteristics and length of stay in the hospitalized  SARS-CoV-2 PCR positive patients at UMMC that have Acute Encephalopathy (AE) and related diagnostic  synonyms.
COVID-19 is a viral illness that is caused by Severe Acute Respiratory Syndrome Coronavirus type 2  (SARS-CoV-2). This was first reported in December 2019, but has spread to many countries affecting  nearly 39 million people, causing more than 1 million deaths so far globally. The pandemic has affected  more than 100,000 people in Mississippi leading to over 6000 hospitalizations to date. Though the  disease has primarily affected the respiratory system, its neurological implications are being increasingly reported. Encephalopathy is the most commonly reported neurological manifestation.
In hospitalized patients who had a positive SARS-CoV-2 PCR test, we used diagnostic codes G93.40 (encephalopathy unspecified), G93.41 (metabolic encephalopathy), G92 (toxic encephalopathy), R41.82  (altered mental status) and R41.0 (delirium/disorientation) to obtain patient data for the study. We have  obtained de-identified patient data from EPIC using Patient Cohort Explorer at UMMC till September 30,  2020. Multiple variables were compared.
We had a total 1016 patients that were admitted with SARS-CoV-2 PCR test positive and 94 patients had  AE and 922 patients did not have AE. The mean age of patients with AE was 64 years (Standard  Deviation (SD) of 16) and without AE was 40 years (SD of 23) (p value <0.001). Males had more AE  compared to females (53% vs 47%, p value 0.018). AE was more prevalent in Caucasians than African  Americans (p value < 0.001). Length of stay was significantly higher in patients with AE (mean of 15 days with SD of 13) compared to 2 days (SD of 5) in non-AE patients (p value <0.001).
Length of stay is significantly higher in COVID- 19 positive patients with Acute Encephalopathy.
Authors/Disclosures
Sushma Edara, MBBS
PRESENTER 		Sushma Edara has nothing to disclose.
Sushma Edara, MBBS Sushma Edara has nothing to disclose.
No disclosure on file
Sushma Edara, MBBS Sushma Edara has nothing to disclose.
No disclosure on file